Article
Expression profile and in vitro blockade of programmed death-1 in human papillomavirus-negative head and neck squamous cell carcinoma.
Head & neck - 1 Aug 2015
Malm Ian-James, Bruno Tullia C, Fu Juan, Zeng Qi, Taube Janis M, Westra William, Pardoll Drew, Drake Charles G, Kim Young J
Abstract excerpt
BACKGROUND: Treatment with a blocking programmed death-1 (αPD-1) antibody recently showed clinical efficacy for various tumor types. In this study, we characterized the expression profile of PD-1/programmed death-ligand-1 (PD-L1) and the potential of PD-1 blockade in human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC). METHODS: Lymphocytes from peripheral blood, draining lymph nodes,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
